| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |